Canada
Discovery of new drugs follows company decision to extend research outside of tryptamine class, i.e. psilocybin and DMT
Hi, what are you looking for?
Mugglehead Investment Magazine
Psychedelics
Psychedelics
Mexican clinical practice releases 'most complete and up-to-date known summary' regarding plant-derived psychoactive substance
Business
The psilocybin producer will be working with the Knowde Group, Inc., BC Green Pharmaceuticals Inc. and Promises Innovative Recovery (PIR)
Canada
Application follows successful pre-clinical animal studies at the University of Arkansas
Canada
Novel proprietary psychedelic molecule continues to demonstrate potential for treating cocaine dependency
Psychedelics
Biopharmaceutical company administers optimized form of LSD in Phase 2b dose-optimization trial
Psychedelics
New York law firm forms multidisciplinary association intended to serve the psychedelic industry
Cannabis
New license is the final required step before administering doses to study participants
Business
COO Kevin Nicholson was appointed as the new CEO
Canada
Vancouver producer to supply synthetic psychedelic compounds to designated investigators and companies
